Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
5.72
+0.12 (2.14%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $6.47 million as of April 28, 2026. Its market cap has decreased by -77.97% in one year.
Market Cap
6.47M
Enterprise Value
1.89M
1-Year Change
-77.97%
Ranking
Category
Stock Price
$5.72
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $6.47M, a decrease of -97.78%. That is a compound annual growth rate of -30.21%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptorum Group | 7.31M |
| Acurx Pharmaceuticals | 7.27M |
| Immuron | 7.23M |
| Xenetic Biosciences | 6.99M |
| Can-Fite BioPharma | 6.95M |
| Alaunos Therapeutics | 6.56M |
| FibroBiologics | 6.45M |
| XTL Biopharmaceuticals | 6.33M |